Merck | MRK - Ebitda



金融业
股票价格
USD 147.37
资产
USD 129.8B
现金及等价物
USD 6.85B
销售成本
USD 3.14B
流动资产
USD 36.68B
流动负债
USD 27.73B
债务
USD 49.12B
股息收益率
2.62
EBIT
USD 840M
EBITDA
USD -1.54B
员工
75K
EPS每股收益
USD -0.13
股本和储备
USD 41.93B
销售毛利
USD 12.09B
债务利息支出
USD 525M
利息收入
USD 35M
贷款资金
USD 51.08B
市值
USD 367.94B
净收入
USD -1.34B
营业费用
USD 15.77B
营业利润
USD 840M
普通股股本
USD 2.47B
PE价格收益
32.26
税前利润
USD -3.53B
销售收入
USD 16.6B
销售和管理费用
USD 2.89B
股票
USD 6.21B
贸易债权人
USD 3.83B
应收帐款人
USD 12.21B


Ebitda 更改 日
AbbVie USD 3.69B 1.68B 2026-03
Abbott USD 2.43B 844M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
Amgen USD 3.86B 1.28B 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Drreddys Laboratories INR 8.63B 12.96B 2026-03
Eli Lilly USD 10.29B 1.86B 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.77B 1.98B 2026-03
J&J USD 8.99B 721M 2026-06
Medtronic USD 2.63B 174M 2026-06
Merck USD -1.54B 7.84B 2026-03
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Novo Nordisk DKK 37.36B 2.64B 2026-06
Pacira USD 48.67M 8.43M 2026-06
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 6.01B 18M 2026-06
Phibro Animal Health USD 68.1M 6.2M 2025-12
Prestige Brands USD 61.24M 23.31M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sanofi EUR 2.72B 2.94B 2026-03
United Therapeutics USD 355M 11.1M 2026-06
Zoetis USD 939M 0 2026-03